Produktname:5,8-Bis(5-bromothiophen-2-yl)-6,7-difluoro-2,3-bis(3-(hexyloxy)phenyl)quinoxaline
IUPAC Name:5,8-bis(5-bromothiophen-2-yl)-6,7-difluoro-2,3-bis[3-(hexyloxy)phenyl]quinoxaline
- CAS:1416047-44-3
- Molekulare Formel:C40H38Br2F2N2O2S2
- Reinheit:97%
- Katalognummer:CM222036
- Molekulargewicht:840.68
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1416047-44-3
- Molekulare Formel:C40H38Br2F2N2O2S2
- Schmelzpunkt:-
- SMILES-Code:CCCCCCOC1=CC(C2=NC3=C(C4=CC=C(Br)S4)C(F)=C(F)C(C5=CC=C(Br)S5)=C3N=C2C6=CC=CC(OCCCCCC)=C6)=CC=C1
- Dichte:
- Katalognummer:CM222036
- Molekulargewicht:840.68
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.